IVAN ROSAS to Hydroxychloroquine
This is a "connection" page, showing publications IVAN ROSAS has written about Hydroxychloroquine.
Connection Strength
0.300
-
Circulating Biomarkers From the Phase 1 Trial of Sirolimus and Autophagy Inhibition for Patients With Lymphangioleiomyomatosis. Chest. 2018 11; 154(5):1070-1082.
Score: 0.158
-
Sirolimus and Autophagy Inhibition in Lymphangioleiomyomatosis: Results of a Phase I Clinical Trial. Chest. 2017 06; 151(6):1302-1310.
Score: 0.142